EDN1 and autosomal dominant polycystic kidney disease: Endothelin-1 (ET-1), an endothelium-derived vasoconstrictor and pro-fibrotic peptide [4–6], has emerged as a possible therapeutic target for inhibiting cyst growth and interstitial fibrosis in ADPKD.